These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9276304)

  • 1. Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory.
    Steinberg DA; Lehrer RI
    Methods Mol Biol; 1997; 78():169-86. PubMed ID: 9276304
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic interactions between mammalian antimicrobial defense peptides.
    Yan H; Hancock RE
    Antimicrob Agents Chemother; 2001 May; 45(5):1558-60. PubMed ID: 11302828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tachyplesin and anti-lipopolysaccharide factor.
    Muta T; Iwanaga S
    Methods Mol Biol; 1997; 78():63-71. PubMed ID: 9276297
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli.
    Wu M; Maier E; Benz R; Hancock RE
    Biochemistry; 1999 Jun; 38(22):7235-42. PubMed ID: 10353835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro bioassay method for antiamoebin.
    Panse MV; Nair KR
    Hindustan Antibiot Bull; 1974 May; 16(4):202-5. PubMed ID: 4461714
    [No Abstract]   [Full Text] [Related]  

  • 6. Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds.
    Rao AG
    Arch Biochem Biophys; 1999 Jan; 361(1):127-34. PubMed ID: 9882437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.
    Tam JP; Lu YA; Yang JL
    Biochem Biophys Res Commun; 2000 Jan; 267(3):783-90. PubMed ID: 10673369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmotic stress in viable Escherichia coli as the basis for the antibiotic response by polymyxin B.
    Oh JT; Van Dyk TK; Cajal Y; Dhurjati PS; Sasser M; Jain MK
    Biochem Biophys Res Commun; 1998 May; 246(3):619-23. PubMed ID: 9618261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of antibacterial activities of the bactericidal/permeability-increasing protein in natural biological fluids.
    Weiss J
    Methods Mol Biol; 1997; 78():217-31. PubMed ID: 9276307
    [No Abstract]   [Full Text] [Related]  

  • 10. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides.
    Campos MA; Vargas MA; Regueiro V; Llompart CM; Albertí S; Bengoechea JA
    Infect Immun; 2004 Dec; 72(12):7107-14. PubMed ID: 15557634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mig-14 is a Salmonella gene that plays a role in bacterial resistance to antimicrobial peptides.
    Brodsky IE; Ernst RK; Miller SI; Falkow S
    J Bacteriol; 2002 Jun; 184(12):3203-13. PubMed ID: 12029036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eukaryotic expression and antimicrobial spectrum determination of the peptide tachyplesin II.
    Xu F; Meng K; Wang YR; Luo HY; Yang PL; Wu NF; Fan YL; Yao B
    Protein Expr Purif; 2008 Apr; 58(2):175-83. PubMed ID: 18249136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a cytotoxic cationic antibacterial peptide in Escherichia coli using two fusion partners.
    Chen YQ; Zhang SQ; Li BC; Qiu W; Jiao B; Zhang J; Diao ZY
    Protein Expr Purif; 2008 Feb; 57(2):303-11. PubMed ID: 17977015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of the lipopolysaccharide deacylase PagL from latency compensates for a lack of lipopolysaccharide aminoarabinose modification-dependent resistance to the antimicrobial peptide polymyxin B in Salmonella enterica.
    Kawasaki K; China K; Nishijima M
    J Bacteriol; 2007 Jul; 189(13):4911-9. PubMed ID: 17483225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of tachyplesin III against Pseudomonas aeruginosa.
    Cirioni O; Giacometti A; Kamysz W; Silvestri C; Riva A; Della Vittoria A; Abbruzzetti A; Lukasiak J; Scalise G
    Peptides; 2007 Apr; 28(4):747-51. PubMed ID: 17331619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, conformational analysis and biological studies of cyclic cationic antimicrobial peptides containing sugar amino acids.
    Chakraborty TK; Koley D; Ravi R; Krishnakumari V; Nagaraj R; Kunwar AC
    J Org Chem; 2008 Nov; 73(22):8731-44. PubMed ID: 18937406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli.
    Kim HK; Chun DS; Kim JS; Yun CH; Lee JH; Hong SK; Kang DK
    Appl Microbiol Biotechnol; 2006 Sep; 72(2):330-8. PubMed ID: 16421719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia.
    Ghiselli R; Giacometti A; Cirioni O; Orlando F; Mocchegiani F; Pacci AM; Scalise G; Saba V
    J Surg Res; 2001 Oct; 100(2):183-8. PubMed ID: 11592790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial dendrimer active against Escherichia coli biofilms.
    Hou S; Zhou C; Liu Z; Young AW; Shi Z; Ren D; Kallenbach NR
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5478-81. PubMed ID: 19682902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acidic peptide-mediated expression of the antimicrobial peptide buforin II as tandem repeats in Escherichia coli.
    Lee JH; Minn I; Park CB; Kim SC
    Protein Expr Purif; 1998 Feb; 12(1):53-60. PubMed ID: 9473457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.